Busulfan is a cell cycle non-specific alkylating antineoplastic agent belonging to the alkyl sulfonate class, primarily utilized in the treatment of chronic myeloid leukemia and as a conditioning regimen… Read more







Busulfan is a cell cycle non-specific alkylating antineoplastic agent belonging to the alkyl sulfonate class, primarily utilized in the treatment of chronic myeloid leukemia and as a conditioning regimen prior to bone marrow transplantation. Laboratories rely on high-quality reference standards of the busulfan API to ensure precision in analytical testing, method validation, and rigorous quality control protocols. This category encompasses a comprehensive collection of pharmacopeial and non-pharmacopeial impurities, such as various sulfonic acid derivatives and alkylated degradation products, which are essential for conducting detailed impurity profiling. Additionally, stable isotope labelled compounds, including deuterated versions like busulfan-d8, serve as critical internal standards for quantitative analysis in complex biological matrices. By providing these necessary reference materials, analytical laboratories can effectively monitor drug purity and metabolic stability throughout the pharmaceutical development and manufacturing process.